Epsilon Metasul 32MM Acetabular Inserts, Standard and Hooded
by Centerpulse Orthopedics, Inc.
510(k) K033634
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK033634 | Date15 Sep 2004 | StatusActive |
Recalls
-
- Terminated Z-1133-2015
Potential compromise of the inner sterile tray. If a compromised tray is detected, a delay in surgery may result. If undetected breach in both the inner and outer trays were to occur, and there is contamination present, a periprosthetic infection is possible, which could lead to revision.
-
- Terminated Z-2299-2008
The wrong part may be in the package. Package may contain a 28 mm head.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KWA
- Device Class
- Class III
- Regulation
- 21 CFR Part 888.3330
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Epsilon Metasul 32mm Acetabular Inserts are semi-constrained, uncemented acetabular components designed for hip arthroplasty. These inserts are made of a metal alloy and are intended to articulate with femoral components to restore hip function in patients with degenerative joint disease or other conditions requiring total hip replacement.
These inserts are supplied as single-use devices and are classified as Class III under FDA regulations. They are intended for use in orthopedic surgical settings and must be handled under sterile conditions. The 32mm size is available in both standard and hooded variants, ensuring compatibility with various surgical techniques and patient anatomies. The device holds an FDA 510(k) clearance under the traditional pathway, with a classification of substantially equivalent to a predicate device.
Other devices from Centerpulse Orthopedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are these acetabular inserts designed for use with any specific type of femoral component, or do they require a particular matching system?
The Epsilon Metasul 32mm Acetabular Inserts are semi-constrained metal components intended to articulate with femoral components to restore hip function. While the device description does not specify exact femoral component requirements, the design is standardized for compatibility with common femoral implants used in total hip arthroplasty. Compatibility depends on the surgical technique and patient anatomy, with both standard and hooded variants available to accommodate different needs.
How should these inserts be handled and stored to maintain sterility before use?
These inserts are classified as single-use devices and must be handled under sterile conditions, as required for orthopedic surgical settings. They should be stored in their original packaging until use, ensuring the sterile barrier remains intact. Proper storage conditions—such as dry, clean environments away from direct sunlight or extreme temperatures—are critical to preserving sterility and functionality.
What are the key differences between the standard and hooded variants of the 32mm acetabular inserts?
The standard and hooded variants of the Epsilon Metasul 32mm inserts are designed to accommodate different surgical techniques and patient anatomies. The hooded variant likely provides additional coverage or protection for the femoral head, which may be beneficial in cases requiring enhanced stability or specific positioning. The choice between the two depends on the surgeon’s preference and the patient’s unique anatomical requirements.
What regulatory pathway was followed for FDA clearance of these acetabular inserts?
The Epsilon Metasul 32mm Acetabular Inserts received FDA clearance under the traditional 510(k) pathway, with a decision dated September 15, 2004. The device was determined to be substantially equivalent to a predicate device, meeting the requirements for Class III classification under FDA regulations. This pathway ensures compliance with stringent safety and performance standards for orthopedic implants.